Bellevue Group’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-30,478
| Closed | -$1.71M | – | 176 |
|
|
2022
Q3 | $1.71M | Buy |
30,478
+14,684
| +93% | +$822K | 0.02% | 125 |
|
|
2022
Q2 | $817K | Sell |
15,794
-500
| -3% | -$25.9K | 0.01% | 141 |
|
|
2022
Q1 | $1.18M | Sell |
16,294
-300
| -2% | -$21.8K | 0.01% | 143 |
|
|
2021
Q4 | $1.96M | Hold |
16,594
| – | – | 0.02% | 147 |
|
|
2021
Q3 | $2.23M | Buy |
+16,594
| New | +$2.23M | 0.02% | 145 |
|
|
2019
Q1 | – | Sell |
-15,834
| Closed | -$216K | – | 145 |
|
|
2018
Q4 | $216K | Sell |
15,834
-600
| -4% | -$8.19K | 0.01% | 136 |
|
|
2018
Q3 | $470K | Sell |
16,434
-300
| -2% | -$8.58K | 0.03% | 137 |
|
|
2018
Q2 | $458K | Buy |
+16,734
| New | +$458K | 0.04% | 134 |
|